Main > > >AORTIC VALVE (CARDIO.) *

---

Cardio.>Aortic Valve Replacement.
EU Approval Date : 2016. 09.29.
USA Approval Date: 2017. 07.05.
(*) Company; Patents; Product Name &
Web-Site Available on Request.
UpDate: 2020. 08.31.




Cardio.>Rapid Deployment Device for Surgical Aortic Valve Replacement.
EU>CE Mark Date : 2014. 04.04.
USA Approval Date: 2016. 08.15.
(*) Company; Patents; Product Name &
Web-Site Available on Request.
UpDate: 2020. 08.31.




Cardio.>Transcatheter Aortic Valve Implantation (TAVI). Aortic Stenosis Treat.
Approved in CN; EU; JP & USA.
(*) Company; Patents; Product Name &
Web-Site Available on Request.
UpDate: 2020. 09.01.




Cardio.>Transcatheter Aortic Valve Implantation (TAVI). Pre-Operatively Device Sizing & Positioning Evaluation.
Potential Complications Risk Assessment.
Using Computational Modeling & Simula-
tion Technology.
EU Approval Date: 2019. 04.01.
(*) Company; USA Patent APP. & WIPO No.;
TradeMark & Web-Site Available on
Request.
UpDate: 2019. 07.18.

Cardio.>Valves>Repair>Aortic>BiCuspid Annuloplasty Device.
USA Approval Date: 2017. 08.15.
(*) Company; Patent; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 02.24.




Cardio.>Valves>Repair>Aortic>TriCuspid Annuloplasty Device.
EU Approval Year : 2016.
USA Approval Date: 2017. 03.22.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 02.24.

Cardio.>Valves.>Aortic>Replacement>Self-Expanding TransCatheter Valve.
TransCatheter Aortic Valve Replacement (TAVR).
Patients at High Risk for Open Heart Surgery.
Severe Aortic Stenosis Patients.
Sizes: 23mm, 26mm, 29mm and 31mm valves.
EU Approval Year : 2007.
USA Approval Date: 2014. 06.12.
(*) Company; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2019. 08.13.




Cardio.>Valves.>Aortic>Replacement>Self-Expanding TransCatheter Valve.
TransCatheter Aortic Valve Replacement (TAVR).
Patients at High Risk for Open Heart Surgery.
Severe Aortic Stenosis Patients.
Size: 34 mm.
EU Approval & Launch Date: 2017. 01.17.
(*) Company; Patents; TradeMark & Web-
Sites Available on Request.
UpDate: 2019. 08.13.




Cardio.>Valves.>Aortic>Replacement>Self-Expanding TransCatheter Valve.
TransCatheter Aortic Valve Replacement (TAVR).
TransCatheter Valve-In-Valve Procedures.
First TAVR Device Indicated for Replacement of Failed Surgical Heart Valves Expands Patient Population That Can Benefit from Minimally Invasive Procedure.
Each year, approximately 200,000 people worldwide receive surgical aortic valves, which typically last 15 years or more. When a surgical valve degenerates over time, patients may require another valve replacement. However, some patients are too sick or frail for a second open-heart surgery, and the transcatheter VIV procedure may now provide them with a new treatment option.
EU Approval Date : 2013. 05.
USA Approval Date: 2015. 03.31.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 08.14.




Cardio.>Valves>Replacement>Aortic>Stent-Less Valve.
Stented-Like Implantability.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 02.21.




Cardio.>Valves>Replacement>Aortic>Trans-
Catheter Aortic Valve Replacement (TAVR).
One-Year Results Real World Study Re-
sults>Reduced Severe Aortic Stenosis.
EU Approval Year: 2012.
(*) Company; Patent; Press Release Web-
Site & TradeMark Available on
Request.
UpDate: 2019. 03.11.




Cardio.>Valves>Replacement>Aortic>Val-
salva Conduit.
(*) Company; Patents & Web-Site Avai-
lable on Request.
UpDate: 2019. 02.23.




Cardio.>Valves.>Aortic>Replacement>with Glide Technology (GT).
EU Approval Date : 2010. 03.03.
EU Launch Date : 2016. 04.07.
USA Approval Date: ?
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 03.14.






>AORTIC VALVE (CARDIO.) *'s products
This section has no products